
Fin d'année 31 Juillet 2024 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Return on Assets (%) | -47.002 | -2.427 | -211.409 | -151.035 | -288.903 | -283.749 |
Return on Equity (%) | -47.343 | -2.445 | -220.217 | -200.157 | 300.656 | 72.591 |
Return on Invested Capital (%) | -48.309 | N/A | -186.812 | -130.408 | 808.015 | 138.562 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.062 | 0.06 | 0.072 | 0.005 | -0.043 | -0.063 |
Earnings Per Share | -0.015 | -0.001 | -0.093 | -0.069 | -0.058 | -0.037 |
Cash Per Share | 0.001 | 0.001 | 0.073 | 0.016 | 0.014 | 0.008 |
Working Capital Per Share | 0.062 | 0.06 | 0.072 | 0.005 | -0.018 | -0.025 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.015 | -0.001 | -0.093 | -0.069 | -0.058 | -0.037 |
EBITDA Per Share | -0.015 | -0.001 | -0.093 | -0.069 | -0.058 | -0.037 |
Free Cash Flow Per Share | -0.015 | -0.001 | -0.093 | -0.069 | -0.058 | -0.037 |
Fin d'année 31 Juillet 2024 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 6,7M | 6,7M | 32,59M | 37,09M | 39,79M | 44,79M |
Capitalisation boursière | 6,94M |
Ratio cours/bénéfice | -3,8 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 18,18 |
Ratio prix/valeur comptable | -2,22 |
Rendement de dividende | - |
Actions en circulation | 44,79M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales